Substitution of phenylalanine for tyrosine-809 in the human colony-stimulating factor 1 receptor (CSF-1R) inhibited its ability to transduce ligand-dependent mitogenic signals in mouse NIH 3T3 cells. When combined with an "activating" mutation at codon 301 that induces constitutive CSF-1R tyrosine kinase activity, the codon 809 mutation suppressed ligand-independent cell transformation. Comparative mapping of tryptic phosphopeptides from mutant and wild-type CSF-1R indicated that tyrosine-809 is a site of ligand-dependent receptor phosphorylation in vivo. The mutant receptor was active as a tyrosine kinase in vitro and in vivo, underwent CSF-1-dependent association with a phosphatidylinositol 3-kinase, and induced expression of the protooncogenes
wild-type CSF-1R indicated that tyrosine-809 is a site of ligand-dependent receptor phosphorylation in vivo. The mutant receptor was active as a tyrosine kinase in vitro and in vivo, underwent CSF-1-dependent association with a phosphatidylinositol 3-kinase, and induced expression of the protooncogenes c-fos and junB, underscoring its ability to trigger some of the known cellular responses to CSF-1. The mutant receptor is likely to be impaired in its ability to interact with critical cellular effectors whose activity is required for mitogenesis.
The effects of colony-stimulating factor 1 (CSF-1) on the proliferation, differentiation, and survival of mononuclear phagocytes are mediated through its binding to a single class of high-affinity receptors (CSF-1R) that have an intrinsic protein-tyrosine kinase (PTK) activity (1) . CSF-1 binding leads to activation of the receptor kinase (2-4), crossphosphorylation of receptor subunits (5) , and rapid receptor downmodulation (6) (7) (8) . CSF-1R PTK activity is essential for signal transduction (8) and enables mononuclear phagocytes to traverse the G1 phase of the cell cycle (1, 9, 10) . The interaction of the tyrosine-phosphorylated receptor with other cellular proteins and/or their phosphorylation on tyrosine must therefore trigger a series of biochemical events that culminate in DNA synthesis and mitogenesis. Consistent with these observations, CSF-1R variants containing "activating" mutations in their extracellular domain exhibit ligand-independent PTK activity, thereby providing sustained mitogenic signals for cell transformation (11) (12) (13) (14) .
Candidate substrates for receptor tyrosine kinases include phosphatidylinositol (PtdIns) 3-kinase (15, 16) , phospholipase C-'yl (PLC-,yl) (17) (18) (19) (20) , the raf-l-encoded serine kinase (21, 22) , and the p21s GTPase-activating protein, GAP (23) (24) (25) (26) . These proteins coprecipitate in immune complexes with the ligand-stimulated B-type platelet-derived growth factor receptor (PDGF-R), and their binding to PDGF-R can be selectively disrupted by mutation of sites of receptor "autophosphorylation" (25, 27, 28) . Activation of PDGF-R might induce the translocation of these effector molecules from the cytoplasm to the plasma membrane, resulting in their allosteric activation through direct receptor binding and/or tyrosine phosphorylation.
Although CSF-1R is structurally related to B-type PDGF-R (29) and appears to be derived from a duplication of the same ancestral gene (30) , it neither phosphorylates nor coprecipitates in immune complexes with PLC-yl (31), the raf-) serine kinase (J.R.D. and C.J.S., unpublished data), or GAP (26) but does undergo a ligand-dependent association with Ptdlns 3-kinase (32, 33) . Cross-phosphorylation of a PTK-inactive CSF-1R mutant by an enzymatically competent receptor subunit was sufficient to trigger its binding to Ptdlns 3-kinase, whereas deletion of two sites of tyrosine phosphorylation (Tyr-699 and Tyr-708) within the CSF-1R "kinase insert" (KI) domain reduced but did not completely eliminate its association with this enzyme (33) . Mutations at other sites of tyrosine phosphorylation within CSF-1R might therefore generate receptors that are selectively impaired in signalresponse coupling. We now report that a CSF-1R mutant containing a phenylalanine-for-tyrosine substitution at codon 809 binds CSF-1, retains PTK activity, and regulates the expression of two early response genes but is severely impaired in inducing mitogenesis. (33) . The products of the two reactions were then mixed and coamplified for an addi-6739 tional 20 cycles using primers A and D. The amplified fragment was digested with Sac I (at c-fms nucleotides 2560 and 3144) and recloned into M13, and several independent clones were subjected to nucleotide sequencing analysis. A clone encoding (11, 12) . Cell lines expressing mutant receptors were obtained by cell sorting using a monoclonal antibody to human CSF-1R (12, 35) . Biological and biochemical characterization of a CSF-1R mutant lacking the KI domain was described previously (33) .
MATERIALS AND METHODS
Other Biochemical Techniques. Procedures for metabolic labeling with [35S]methionine (36) or [32P]orthophosphate (4) , immunoprecipitation and gel electrophoresis (36) , immune complex tyrosine kinase (37) and PtdIns 3-kinase (33) assays, phospho amino acid analysis and two-dimensional mapping of tryptic phosphopeptides (8) , immunoblotting with antibodies to phosphotyrosine (4) , enumeration of 125I-CSF-1 binding sites by equilibrium binding (12) , growth of cell lines in serum-free medium (38) , and Northern blot analysis of RNA (39) (11, 12, 38) . Because mouse CSF-1 does not bind with high affinity to human CSF-1R, autocrine transformation is precluded unless human CSF-1 cDNA is coexpressed (11 (11, 12) . Sheared high molecular weight NIH 3T3 cell DNA (5 ,g) was used as carrier. One day after transfection, the cells were trypsinized and replated in three 60-mm diameter dishes and fed every 3 days thereafter. Foci were counted 18-21 days after transfection. The data represent averages of quadruplicate experiments. Cotransfection of c-fms[301E] plus CSF-1 cDNA does not increase its transforming efficiency (14) .
was also suppressed by the Phe-809 mutation (Table 1) , again suggesting that it severely impaired but did not completely abrogate cell transformation.
Tyrosine Phosphorylation Mediated by CSF-lR[809F]. The levels of the mature cell surface form of CSF-1R detected in a cell line expressing the mutant receptor were 1.5-fold higher than those detected in cells synthesizing wild-type CSF-1R (-30,000 binding sites per cell by Scatchard analysis). Further studies revealed that CSF-lR[809F] was glycosylated and transported to the cell surface with normal kinetics, bound CSF-1 with high affinity, and underwent accelerated ligand-induced turnover, indicating that the mutation did not affect normal receptor trafficking (data not shown). The mutation did not appear to perturb CSF-1R PTK activity as assessed by several criteria. First, in immune complex kinase reactions in which receptors are phosphorylated only on tyrosine residues (2, 4), the activity of CSF-lR[809F] was indistinguishable from that of the wild-type receptor (Fig.  la) . Both receptors were also equally active in phosphorylating the heterologous substrate poly(Glu-Tyr) in vitro (data not shown). Second, CSF-1 stimulation of cells bearing either mutant or wild-type receptors induced similar levels of receptor tyrosine phosphorylation in vivo (Fig. lb) . Third, anti-phosphotyrosine immunoblots of lysates from CSF-1-stimulated cells showed that other cellular proteins were phosphorylated on tyrosine with a pattern, intensity, and kinetics similar to those induced by wild-type CSF-1R (Fig.   lc) .
CSF-1R immunoprecipitated from cells metabolically labeled with [32P]orthophosphate contains phosphoserine and acquires phosphotyrosine only after CSF-1 stimulation (4). Trypsin digestion of the mature wild-type and mutant CSF-1R glycoproteins recovered from unstimulated cells yielded four major phosphoserine-containing peptides (Fig. 2 a and b , peptides [1] [2] [3] [4] as well as other, minor ones. After CSF-1 stimulation for 5 min at 37°C, at least six additional phosphopeptides were recovered from the wild-type receptor (Fig. 2c, peptides A-F (Fig. 2d) , suggesting that it contained Tyr-809. Amino acid sequence data are as yet unavailable, precluding a more definitive assignment.
Because several major sites of tyrosine phosphorylation in both the murine (41, 42) (Fig. 2e, peptides B, D, F, and G) . A mixing experiment confirmed that peptides B, D, and F corresponded to phosphopeptides in the wild-type receptor (Fig. 2f) . Peptide G, present as a minor spot in maps of wild-type CSF-1R (Fig.  2c) , was phosphorylated to a greater extent in CSF-1R[AKI] molecules (Fig. 2e) (32, 33) . Its association is triggered by tyrosine phosphorylation of CSF-1R and is significantly reduced for mutant receptors lacking the KI domain (33) . In the absence of CSF-1, increased levels of PtdIns 3-kinase were detected in immunoprecipitates containing constitutively activated CSF-1R mutants, whereas lipid kinase activity did not associate with tyrosine kinase-defective receptors unless they were phosphorylated on tyrosine in trans (33 (Table 2) . Thus, the association of CSF-1R with PtdIns 3-kinase is not sufficient for mitogenesis.
Because the failure of CSF-lR[809F] to induce mitogenesis was not manifested by a loss of receptor PTK activity, the expression of several "immediate early response" genes was evaluated after stimulation of quiescent cells with saturating concentrations of CSF-1. Ligand treatment rapidly induced the transient expression of both c-fos andjunB mRNAs with kinetics similar to those seen in cells expressing wild-type CSF-1R (Fig. 3) Proc. Natl. Acad. Sci. USA 87 (1990) :";.,
A" I'WI -F .6 t, Receptor-bearing cells were plated at 2 x 106 cells per 100-mm dish in medium containing 10%o calf serum and were transferred to medium containing 0.1% serum to render them quiescent. Cells starved for serum for 24 hr were stimulated for 5 min by addition of 4.4 nM purified recombinant human CSF-1 to the same medium. Cells expressing CSF-1R[809F] expressed about 1.5-fold more CSF-1 binding sites than those expressing wild-type CSF-1R. Cell lysates adjusted for equal amounts of protein were precipitated with antibodies to phosphotyrosine or to CSF-1R, and immune complexes were assayed for PtdIns 3-kinase activity by using thin-layer chromatography to resolve the product (16, 33) . Levels of enzyme activity (cpm of chromatographed product generated in a 10-min reaction at 300C) were normalized for cell surface receptor number (33) . Enzyme activities in precipitates from cells expressing wild-type CSF-1R were assigned a relative specific activity of 1.
requirements and enables the cells to proliferate in medium containing CSF-1 (11, 38 (34) . However, tryptic peptides containing Tyr-699 and Tyr-708 are each flanked by tandem basic amino acids, suggesting that they could yield partial cleavage products accounting for additional spots. In contrast, the presence of phosphopeptides D and F in maps of both receptor mutants implies that at least one tyrosine residue other than those now mapped within murine CSF-1R is phosphorylated in vivo in response to ligand.
How might mutation of a single tyrosine residue determine the specificity by which CSF-1R interacts with particular effectors? One possibility is that mutations within the CSF-1R intracellular domain differentially affect the catalytic efficiency of the enzyme for certain substrates. Because the patterns of ligand-induced tyrosine phosphorylation of cellular proteins were not detectably altered by the Tyr-809 mutation, putative critical substrates would have to be relatively nonabundant or phosphorylated at low stoichiometry. Alternatively, phosphorylation of Tyr-809 might trigger an association of CSF-1R with particular enzymes that are translocated to the membrane and allosterically activated through receptor binding. Their phosphorylation on tyrosine might simply result from their interaction with the receptor kinase or could, in turn, regulate their effector functions.
Tyr-809 in CSF-1R corresponds to Tyr-857 in human PDGF-R, which together with Tyr-751 in the KI domain represent major sites of PDGF-induced phosphorylation in vivo (27) . Mutation of Tyr-857 (or its Tyr-825 homolog in murine PDGF-R) reduced PDGF-R binding to GAP by 80% (25) but did not affect its association with PtdIns 3-kinase (27, 28) , whereas mutation of Tyr-751 (25) or deletion of the PDGF-R KI domain (24, 44) inhibited its binding to both molecules. Both classes of PDGF-R mutants were impaired in their ability to stimulate DNA synthesis but mediated some early responses to PDGF (44) (45) (46) , consistent with the hypothesis that autophosphorylation provides signals that facilitate interactions with cellular proteins, only some ofwhich directly contribute to mitogenesis.
What motifs in candidate effector molecules might facilitate their binding to phosphorylated receptors? Both GAP and PLC-yl (but not the raf-l-encoded kinase) contain SH2 and SH3 domains (47) that might enable them to interact with phosphotyrosine residues within particular sequence contexts. Moreover, the crk oncogene product, which lacks a PTK catalytic domain, contains SH2 and SH3 sequences and associates with endogenous protein kinases to induce cell transformation (48, 49) . Although proteins such as PLC-yl, GAP, and the raf-) kinase bind to ligand-activated PDGF-R and might potentially interact with each other within a signal-transduction complex (26, 28, 50) , the lack of direct CSF-1R binding or phosphorylation of these proteins implies that their activities are coupled to CSF-1R by an indirect mechanism or, alternatively, are not required for CSF-1-induced mitogenesis.
